Pioneering new therapies for cancer


MEI Pharma Reports Second Quarter Fiscal Year 2017 Results
Feb 8, 2017 | Press Release

Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (ASH)
Press Release | Presentation

MEI Pharma Hosts Annual Meeting of Stockholders
Dec 1, 2016 | Webcast

Formulation Selection and Development for ME-401 (AAPS)
Nov 15, 2016 | Poster